Clinical Trial: Response-adapted Luvometinib With or Without Cytarabine in Langerhans Cell Histiocytosis (China)

China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Response-adapted Luvometinib With or Without Cytarabine in Langerhans Cell Histiocytosis'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600129807

Registration Time: 2026/08/10

Type: Interventional study

Primary Sponsor: Shanghai Ninth Peoples Hospital,Shanghai JiaoTong University School of Medicine

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=337528

Published by HT Digital Content Services with permission from Health Daily Digest....